Skip to content
Screener

Viridian Therapeutics, Inc. VRDN Segment Reporting, Other Segment Item, Amount

Segment Reporting, Other Segment Item, Amount at other companies

ConocoPhillips logo
ConocoPhillipsCOP
$7.45B+42.3%
PRA Group logo
PRA GroupPRAA
$35.48M-6.5%
Matthews International logo
Matthews InternationalMATW
-$15.63M-883%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$25.48M+4,316%
Radiant Logistics logo
Radiant LogisticsRLGT
-$271K-113%
Microbot Medical logo
Microbot MedicalMBOT
$557K+7.3%

Segments

By segment

See full
Reportable Segment$504K+108%

Other financials

Income statement

See full
Revenue$284.0K+279%
Operating income-$126.3M-18.3%
Net income-$127.1M-26.2%
EPS (diluted)-$1.15-5.5%

Balance sheet

See full
Cash & equivalents$165.0M+40.6%
Total debt$114.4M+395%
Total equity$662.1M+28.5%
Total assets$1.1B+88.4%

Cash flow

See full
Operating cash flow-$105.3M-39.7%
CapEx$1.3M+3,010%
Free cash flow-$106.6M-41.4%

Valuation

See full
Market cap$2.55B+81.7%
Enterprise value$2.5B+90.9%
P/S35.9×-4,565×

Profitability

See full
Gross margin36.3%—
Operating margin-569.7%-284pp
Net margin-544.1%-271pp
FCF margin-471%-235pp

Returns & leverage

See full
Return on equity-65.7%-0.1pp
Debt / equity0.2×+0.1×
Current ratio16.9×+5.9×